SCHEMBL13077429

SCHEMBL13077429

C=C(C)OC(=O)NC(C(=O)OCC(C)(C)C(=O)OCI)C(C)C

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CTSS P25774 1/20 0.31
CTSK P43235 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3738967 0.83 CTSK (0.47) CTSSCTSK
SCHEMBL13039819 0.83 CTSK (0.47) CTSSCTSK
SCHEMBL3728988 0.75 CTSB (0.50) CTSSCTSK
SCHEMBL3740281 0.75 CTSB (0.50) CTSSCTSK
SCHEMBL3729638 0.73 CTSS (0.51) CTSSCTSK
SCHEMBL3729640 0.73 CTSS (0.51) CTSSCTSK
SCHEMBL3731957 0.71 CTSK (0.46) CTSSCTSK
SCHEMBL7782701 0.71 CYP3A4 (0.46) CTSSCTSK
SCHEMBL16552568 0.70 CTSK (0.54) CTSSCTSK
SCHEMBL9972923 0.70 CTSK (0.54) CTSSCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7825238-B2 Antiviral methods employing double esters of 2′, 3′-dideoxy-3′-fluoroguanosine MEDIVIR AB (SE) 2010-11-02 US disclosed